Safety study of a vaginal gel for healthy women
Part of Infections clinical trials.
This trial tests a gel placed in the vagina to see if it is safe. Healthy women with regular periods who have a steady partner may join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy woman between 18 and 45 with regular periods
- You can read and consent in English and have had a gynecological exam before
- You agree to frequent clinic visits over at least 53 days
- You agree to STI testing and a Pap smear
- You agree to no sexual intercourse or use of vaginal products until the study drug is cleared
- If you have a male partner, you must use two forms of birth control (like condoms plus an IUD or hormonal method) during sex after clearance
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of an investigational drug given vaginally to healthy Chinese women. It aims to see if the drug is safe and how the body processes it.
This trial tests a new vaginal film (KB15A) in healthy women aged 18–45. The film is placed in the vagina to see if it's safe. It may be a new way to protect against certain infections.
This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.
This trial tests a new vaginal gel that uses acetic acid to prevent pregnancy. It may be an option for women who want a non-hormonal birth control method.
This trial tests a gel called YASO GEL to see if it's safe and how the body handles it. It's for healthy women aged 18-45 and men aged 18 and older who are not using it as birth control.
This study is looking at the bacteria living in the vagina to understand what makes a healthy microbiome in African women. You will provide self-collected swabs and attend visits to help researchers learn more about vaginal health.
Hear when a new HIV-1-infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.